Ancora Advisors, LLC Novartis Ag Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Ancora Advisors, LLC holds 3,076 shares of NVS stock, worth $320,765. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,076

Previous 3,137 1.94%

Holding current value

$320,765

Previous $333,000 6.01%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $6,473 - $7,374	-61 Reduced 1.94%	3,076 $353,000
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $6,294 - $7,301	68 Added 2.22%	3,137 $333,000
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $29,434 - $32,391	-319 Reduced 9.42%	3,069 $309,000
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $11,083 - $12,300	117 Added 3.58%	3,388 $345,000
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $6,568 - $7,448	-71 Reduced 2.12%	3,271 $330,000
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $8,008 - $9,807	-106 Reduced 3.07%	3,342 $303,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $522 - $610	-7 Reduced 0.2%	3,448 $262,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $12,963 - $15,093	-161 Reduced 4.45%	3,455 $292,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $240 - $271	3 Added 0.08%	3,616 $317,000
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $8,812 - $9,968	-110 Reduced 2.95%	3,613 $309,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $215,668 - $238,479	-2,706 Reduced 42.09%	3,723 $325,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $227,839 - $265,060	2,786 Added 76.48%	6,429 $526,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $2,557 - $2,824	30 Added 0.83%	3,643 $332,000
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $1,920 - $2,264	-23 Reduced 0.63%	3,613 $309,000
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $15,457 - $18,697	198 Added 5.76%	3,636 $344,000
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $13,596 - $15,304	168 Added 5.14%	3,438 $300,000
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $21,201 - $29,703	-300 Reduced 8.4%	3,270 $270,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $3,507 - $3,864	-41 Reduced 1.14%	3,570 $311,000
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $84,297 - $103,750	-1,118 Reduced 23.64%	3,611 $330,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $2,560 - $2,929	34 Added 0.72%	4,729 $454,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $314,283 - $363,533	4,695 New	4,695 $405,000
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $404,519 - $457,179	-6,232 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $67,785 - $81,036	963 Added 18.28%	6,232 $504,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $72,330 - $77,640	1,000 Added 23.42%	5,269 $443,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $316,503 - $329,865	4,269	4,269 $366,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Novartis Ag Transaction History